홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Oxalyl chloride → HCID 178418553, 화합물

HRID 4773
노트
인쇄 미리보기

반응식

HRID 4773 반응식
C(Cl)(=O)C(Cl)=O.C([NH:26][C:27]1[S:28][CH:29]=[C:30](/[C:32](=[N:36]/[O:37][CH:38]2[CH2:42][CH2:41][NH:40][C:39]2=[O:43])/[C:33]([OH:35])=O)[N:31]=1)(C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[NH2:44][C@@H:45]1[C:62](=[O:63])[N:47]2[C:48]([C:59]([O-:61])=[O:60])=[C:49]([CH2:52][N+:53]3[CH:58]=[CH:57][CH:56]=[CH:55][CH:54]=3)[CH2:50][S:51][C@H:46]12.C1(N)C(F)=C(F)C(F)=C(N)C=1F.Cl.Cl.C/C(/O[Si](C)(C)C)=N\[Si](C)(C)C>C(Cl)(Cl)Cl.O.C(N(CC)CC)C.CN(C)C=O>[NH2:26][C:27]1[S:28][CH:29]=[C:30](/[C:32](=[N:36]/[O:37][CH:38]2[CH2:42][CH2:41][NH:40][C:39]2=[O:43])/[C:33]([NH:44][C@@H:45]2[C:62](=[O:63])[N:47]3[C:48]([C:59]([O-:61])=[O:60])=[C:49]([CH2:52][N+:53]4[CH:54]=[CH:55][CH:56]=[CH:57][CH:58]=4)[CH2:50][S:51][C@H:46]23)=[O:35])[N:31]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 5

HCID 65578Oxalyl chlorideHCID 149026Tetrafluoro-m-phenylenediamine dihydrochlorideHCID 6913588N,O-bis(trimethylsilyl)acetamideHCID 11055417N-(7-Aminocephem-3-em-3-ylmethyl)pyridinium-4-carboxylateHCID 13335553(2Z)-2-(2-oxopyrrolidin-3-yl)oxyimino-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetic acid

생성물 1

HCID 178418553
HCID 178418553, 화합물

시약·촉매·용매 4

HCID 962Water용매HCID 6212Chloroform용매4회HCID 6228Dimethylformamide용매HCID 8471Triethylamine용매

실험 절차

1.81 g of oxalyl chloride are added at -5° to 0° C. to 45 ml of chloroform containing 1.15 ml of dimethylformamide, and the mixture is stirred at the same temperature for 15 minutes. A solution of 4.90 g of (Z)-2-(2-tritylaminothiazol-4-yl)-2-[(2-pyrrolidon-3-yl)oxyimino]acetic acid (l-isomer) and 0.97 g of triethylamine in 45 ml of chloroform is added to said mixture at -30° C. The mixture is stirred at the same temperature for 5 minutes. Then, a solution of 7β-amino-3-(1-pyridiniomethyl)-3-cephem-4-carboxylate in chloroform (said solution is prepared by suspending 5.8 g of the dihydrochloride of said cephem compound in 45 ml of chloroform and adding 12.7 ml of N,O-bis(trimethylsilyl)acetamide thereto to dissolve said salt therein) is added to the said mixture at -30° to -10° C. After the mixture is stirred at the same temperature for 30 minutes, said mixture is concentrated to dryness under reduced pressure. 100 ml of 80% aqueous formic acid are added to the residue, and said aqueous mixture is stirred at room temperature for one hour. 110 ml of water are added to the mixture, and insoluble materials are filtered off. The filtrate is washed with ethyl acetate and is concentrated to dryness under reduced pressure. The residue thus obtained is dissolved in water and chromatographed on a column of non-ionic polymer resin Diaion HP-20 (registered trade mark, manufactured by Mitsubishi Chemical Industries Ltd., Japan). The column is washed with water, followed by elution with 20% aqueous methanol. The fractions containing the cephalosporin compound are collected and concentrated to dryness under reduced pressure. Acetone is added to the residue, and the resulting powder is collected by filtration. 2.22 g of 7β-{(Z)-2-(2-aminothiazol-4-yl)-2-[(2-pyrrolidon-3-yl)oxyimino]acetamido}-3-(1-pyridiniomethyl)-3-cephem-4-carboxylate (l-isomer) are obtained. Another designation of this levorotatory isomer is shown as 7β-{(Z)-2-(2-aminothiazol-4-yl)-2-[((3S)-2-pyrrolidon-3-yl)oxyimino]acetamido}-3-(1-pyridiniomethyl)-3-cephem-4-carboxylate.

후처리

  1. customat -30° C
  2. stirringThe mixture is stirred at the same temperature for 5 minutes
  3. customis prepared
  4. dissolutionto dissolve
  5. addition) is added to the said mixture at -30° to -10° C
  6. stirringAfter the mixture is stirred at the same temperature for 30 minutes
  7. concentrationis concentrated to dryness under reduced pressure
  8. addition100 ml of 80% aqueous formic acid are added to the residue
  9. stirringis stirred at room temperature for one hour
  10. addition110 ml of water are added to the mixture, and insoluble materials
  11. filtrationare filtered off
  12. washThe filtrate is washed with ethyl acetate
  13. concentrationis concentrated to dryness under reduced pressure
  14. customThe residue thus obtained
  15. customchromatographed on a column of non-ionic polymer resin Diaion
  16. washThe column is washed with water
  17. washfollowed by elution with 20% aqueous methanol
  18. additionThe fractions containing the cephalosporin compound
  19. customare collected
  20. concentrationconcentrated to dryness under reduced pressure
  21. additionAcetone is added to the residue
  22. filtrationthe resulting powder is collected by filtration

출처 및 근거

ORD 기록
ord-956934eb3d094e4c9e92a29f8cc49c84
출처 데이터셋
uspto-grants-1988_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04727071

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트